Molecular imaging plays a central role in modern medicine as well as biomedical research to study regional or systemic tissue properties in a non-invasively manner. It comprises the real-time visualization and quantification of biochemical events at the cellular and molecular level within living cells, biological and artificial tissues and living subjects. The application of molecular imaging techniques, comprising the development and evaluation of novel imaging biomarkers for specific biological and biochemical processes, in combination with traditional imaging modalities, has the potential to provide essential comprehensive information on tumor heterogeneity that benefits in radiation therapy.
Preclinical multimodal molecular imaging and specific biomedical image quantification procedures are useful tools to foster the understanding of the systems biology of tumors, increasing the knowledge about radiobiological aspects and help to facilitate the integration in the field of radiation therapy planning, verification and treatment monitoring.
In this context, a preclinical imaging facility comprising micro-positron-emission-tomography (µPET), micro-single-photon-emission-computed-tomography (µSPECT) and micro-computed-tomography (µCT) is implemented in the research infrastructure of the ion therapy and research center – MedAustron. Collaborative research between the University of Applied Sciences Wiener Neustadt and the Medical University of Vienna, in the field of molecular imaging sciences, medical physics and radiation biology are performed.
Feel free to contact us: FuE@fhwn.ac.at